Nuvation Bio (NUVB) Return on Assets (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Return on Assets for 3 consecutive years, with 0.34% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 68.0% to 0.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.34%, a 68.0% increase, with the full-year FY2025 number at 0.36%, up 62.0% from a year prior.
  • Return on Assets was 0.34% for Q4 2025 at Nuvation Bio, up from 0.35% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.11% in Q1 2024 to a low of 1.17% in Q1 2025.
  • A 3-year average of 0.58% and a median of 0.36% in 2025 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 68bps in 2025; the steepest drop was -106bps in 2025.
  • Nuvation Bio's Return on Assets stood at 0.12% in 2023, then tumbled by -744bps to 1.02% in 2024, then surged by 67bps to 0.34% in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Return on Assets are 0.34% (Q4 2025), 0.35% (Q3 2025), and 0.36% (Q2 2025).